The Patent Finder

Biotime, Inc.

Also on record
Records under this name other than the patents Biotime, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Back to Biotime, Inc.

PatentTitleStatus Expires Confidence
US 10,745,752Methods for telomere length and genomic DNA quality control analysis in pluripotent stem cells
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,961,531Compositions and methods for induced tissue regeneration in mammalian species
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,421,513Compositions and methods for induced tissue regeneration in mammalian species
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,492,400Compositions and methods for induced tissue regeneration in mammalian species
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,404,493Methods for the re-derivation of diverse pluripotent stem cell-derived brown fat cells
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,685,386Methods and compositions for in vitro and in vivo chondrogenesis
Formerly held
Lapsed on the fee record
Ended Apr 1, 2026 · From the USPTO record
Lapsed on the fee recordEnded Apr 1, 2026From the USPTO record
US 9,732,128Methods of modifying transcriptional regulatory networks in stem cells
Formerly held
Lapsed on the fee record
Ended Aug 15, 2025 · From the USPTO record
Lapsed on the fee recordEnded Aug 15, 2025From the USPTO record
US 10,920,191Methods of screening embryonic progenitor cell lines
Formerly held
Lapsed on the fee record
Ended Feb 16, 2025 · From the USPTO record
Lapsed on the fee recordEnded Feb 16, 2025From the USPTO record
US 10,865,383Methods and formulations for orthopedic cell therapy
Formerly held
Lapsed on the fee record
Ended Dec 15, 2024 · From the USPTO record
Lapsed on the fee recordEnded Dec 15, 2024From the USPTO record
US 9,175,263Methods and compositions for targeting progenitor cell lines
Formerly held
Lapsed on the fee record
Ended Nov 3, 2023 · From the USPTO record
Lapsed on the fee recordEnded Nov 3, 2023From the USPTO record
10 of 42 patents shown.
Pro members see all 42.
Pro members: see all 42 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited